Worth reading
72In focus
Scored from 3 of 5 sectionsDirection
Deterioration
Direction inferred from the company’s description.Scale
6200000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Substantial exercise of the 39th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions)
発行・処分する株式数
6,200,000 new shares (0 treasury shares transferred)
Intended allottee
EVO FUND (allottee of the previously issued stock acquisition rights)
Existing Shares and Increase
+6.66%Rate of increase
93,101,408 shares99,301,408Shares
6.66% (6,200,000 shares ÷ 93,101,408 shares outstanding as of 30 June 2026)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥21.0 from 2 July 2026 onward. Details of and the floor under the exercise price adjustment clause: not disclosed
Number of Stock Acquisition Rights
Total issued: 600,000 rights; unexercised as of 30 June 2026: 515,370 rights; currently unexercised: 453,370 rights
Most recent equity financing
The 39th Stock Acquisition Rights issued on 1 June 2026 and allotted to EVO FUND (with an exercise price adjustment clause)
| Item | Details |
|---|---|
| Type of issuance or disposal | Substantial exercise of the 39th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions) |
| Number of shares to be issued or disposed of | 6,200,000 new shares (0 treasury shares transferred) |
| Intended allottee | EVO FUND (allottee of the previously issued stock acquisition rights) |
| Dilution Rate | 6.66% (6,200,000 shares ÷ 93,101,408 shares outstanding as of 30 June 2026) |
| Total number of issued shares | 93,101,408 shares → 99,301,408 shares（6.66%） |
| Exercise price | ¥21.0 from 2 July 2026 onward. Details of and the floor under the exercise price adjustment clause: not disclosed |
| Number of Stock Acquisition Rights | Total issued: 600,000 rights; unexercised as of 30 June 2026: 515,370 rights; currently unexercised: 453,370 rights |
| Most recent equity financing | The 39th Stock Acquisition Rights issued on 1 June 2026 and allotted to EVO FUND (with an exercise price adjustment clause) |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because a substantial number of rights were exercised. The company has provided no specific explanation of the reasons for or background to the exercises.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.